AIH vs. BACK, RDHL, AVTX, PIRS, MBOT, NXGL, DOMH, MNPR, TRIB, and PLAG
Should you be buying Aesthetic Medical International Holdings Group stock or one of its competitors? The main competitors of Aesthetic Medical International Holdings Group include IMAC (BACK), RedHill Biopharma (RDHL), Avalo Therapeutics (AVTX), Pieris Pharmaceuticals (PIRS), Microbot Medical (MBOT), NEXGEL (NXGL), Dominari (DOMH), Monopar Therapeutics (MNPR), Trinity Biotech (TRIB), and Planet Green (PLAG). These companies are all part of the "medical" sector.
Aesthetic Medical International Holdings Group (NASDAQ:AIH) and IMAC (NASDAQ:BACK) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, community ranking, institutional ownership, risk, profitability, media sentiment, valuation, analyst recommendations and earnings.
Aesthetic Medical International Holdings Group has higher revenue and earnings than IMAC.
In the previous week, IMAC had 43 more articles in the media than Aesthetic Medical International Holdings Group. MarketBeat recorded 45 mentions for IMAC and 2 mentions for Aesthetic Medical International Holdings Group. Aesthetic Medical International Holdings Group's average media sentiment score of 1.34 beat IMAC's score of 0.30 indicating that Aesthetic Medical International Holdings Group is being referred to more favorably in the media.
Aesthetic Medical International Holdings Group received 1 more outperform votes than IMAC when rated by MarketBeat users. Likewise, 33.33% of users gave Aesthetic Medical International Holdings Group an outperform vote while only 0.00% of users gave IMAC an outperform vote.
Aesthetic Medical International Holdings Group has a net margin of 0.00% compared to IMAC's net margin of -176.22%. Aesthetic Medical International Holdings Group's return on equity of 0.00% beat IMAC's return on equity.
2.1% of Aesthetic Medical International Holdings Group shares are owned by institutional investors. Comparatively, 5.8% of IMAC shares are owned by institutional investors. 55.1% of Aesthetic Medical International Holdings Group shares are owned by company insiders. Comparatively, 10.0% of IMAC shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Aesthetic Medical International Holdings Group has a beta of -0.21, indicating that its share price is 121% less volatile than the S&P 500. Comparatively, IMAC has a beta of 0.19, indicating that its share price is 81% less volatile than the S&P 500.
Summary
Aesthetic Medical International Holdings Group beats IMAC on 10 of the 13 factors compared between the two stocks.
Get Aesthetic Medical International Holdings Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for AIH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AIH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Aesthetic Medical International Holdings Group Competitors List
Related Companies and Tools
